A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran When Added to Pregabalin in the Treatment of Fibromyalgia.

Trial Profile

A Multicenter, Randomized, Open-Label, Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran When Added to Pregabalin in the Treatment of Fibromyalgia.

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Apr 2011

At a glance

  • Drugs Milnacipran (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Sponsors Forest Laboratories
  • Most Recent Events

    • 16 Apr 2011 Results reporting treatment effects on cognitive function presented at the 63rd Annual Meeting of the American Academy of Neurology.
    • 16 Apr 2011 Results presented at the 63rd Annual Meeting of the American Academy of Neurology.
    • 08 Nov 2010 Results presented at 74th Annual Scientific Meeting of the American College of Rheumatology and the 45th Annual Meeting of the Association of Rheumatology Health Professionals, Nov 1020
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top